3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasms
2
Motor Activity
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Angina, Unstable
1
Interventions
Peripheral Blood Stem Cell Transplantation
18
fludarabine phosphate
17
Cyclophosphamide
17
Busulfan
12
Tacrolimus
11
Methotrexate
8
Cyclosporine
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Mycophenolic Acid
7
Filgrastim
6
peginterferon alfa-2a
5
Etoposide
5
Prednisone
4
Decitabine
4
Cytarabine
4
ruxolitinib
3
fludarabine
3
Radiotherapy
3
Methylprednisolone
3
Carboplatin
3
Aspirin
3
tipifarnib
2
sonidegib
2
merphos
2
liposomal amphotericin B
2
givinostat hydrochloride
2
givinostat
2
aldesleukin
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombocythemia, Essential
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled